Carl Langren
2020
In 2020, Carl Langren earned a total compensation of $1M as Chief Financial Officer at NewLink Genetics, a 27% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $269,926 |
|---|---|
| Option Awards | $253,021 |
| Salary | $389,025 |
| Stock Awards | $70,830 |
| Other | $59,040 |
| Total | $1,041,842 |
Langren received $389K in salary, accounting for 37% of the total pay in 2020.
Langren also received $269.9K in non-equity incentive plan, $253K in option awards, $70.8K in stock awards and $59K in other compensation.
Rankings
In 2020, Carl Langren's compensation ranked 8,454th out of 13,090 executives tracked by ExecPay. In other words, Langren earned more than 35.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,454 out of 13,090 | 35th |
Division Manufacturing | 3,596 out of 5,621 | 36th |
Major group Chemicals And Allied Products | 1,456 out of 2,254 | 35th |
Industry group Drugs | 1,267 out of 1,954 | 35th |
Industry Pharmaceutical Preparations | 936 out of 1,459 | 36th |
Source: SEC filing on April 6, 2021.
Langren's colleagues
We found five more compensation records of executives who worked with Carl Langren at NewLink Genetics in 2020.